China's Biotech Industry

supercat

supercat

Colonel
China's startup NeuroXess is building a factory to mass-produce BCI in the second half of this year.
Please, Log in or Register to view URLs content!

$5.6 billion deal for a cancer drug that can potentially treat some type of lung cancer and colorectal cancer:

JPM26: AbbVie and RemeGen kick off deals with $5.6bn oncology agreement​

Under the agreement, AbbVie will hand over $650m in upfront payments, while committing to pay up to $4.95bn if the therapy meets certain regulatory, development and commercial milestones.

In exchange, RemeGen will grant AbbVie the exclusive development, manufacturing and commercialisation rights to RC148 outside of the Greater China region. RemeGen will be entitled to receive tiered, double-digit royalties on net sales outside of Greater China if RC148 were to make it to market.
Click to expand...
Please, Log in or Register to view URLs content!
 
You must log in or register to reply here.
Top